Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $99,184.70 +1.18%
Ethereum $3,301.07 -1.39%
BNB $624.33 +0.72%
Optimism $2.13 +1.46%
Arbitrum $0.78 -0.08%
Solana $254.78 -0.81%
Polygon $0.48 +5.83%
Cosmos $7.34 +16.13%
Avalanche $39.70 +10.93%

Bitcoin $99,184.70 +1.18%
Ethereum $3,301.07 -1.39%
BNB $624.33 +0.72%
Optimism $2.13 +1.46%
Arbitrum $0.78 -0.08%
Solana $254.78 -0.81%
Polygon $0.48 +5.83%
Cosmos $7.34 +16.13%
Avalanche $39.70 +10.93%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B